Private Wealth Management Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2K Sell
47
-7
-13% -$2.6K ﹤0.01% 412
2026
Q1
$15.8K Sell
54
-9
-14% -$2.96K ﹤0.01% 390
2025
Q4
$22.1K Buy
63
+38
+152% +$12.8K 0.01% 302
2025
Q3
$8.08K Sell
25
-43
-63% -$13.4K ﹤0.01% 594
2025
Q2
$26.4K Buy
68
+5
+8% +$2.01K 0.01% 254
2025
Q1
$27.4K Buy
63
+38
+152% +$15.3K 0.01% 242
2024
Q4
$9.22K Sell
25
-69
-73% -$28.9K ﹤0.01% 501
2024
Q3
$48.9K Hold
94
0.02% 163
2024
Q2
$50.9K Buy
94
+8
+9% +$4.23K 0.02% 156
2024
Q1
$44.6K Hold
86
0.02% 169
2023
Q4
$40.6K Buy
+86
New +$39.8K 0.02% 180

Other funds holding ELV

Private Wealth Management Group's ELV Position: Q2 2026 in Review

Private Wealth Management Group reduced its Elevance Health (ELV) stake by 13% in Q2 2026, selling an estimated $2.6K and leaving 47 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Private Wealth Management Group first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $50.9K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Private Wealth Management Group held 47 shares of Elevance Health worth $18.2K as of Q2 2026.
  • Private Wealth Management Group sold 7 Elevance Health shares in Q2 2026, an estimated $2.6K.
  • Elevance Health made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #412 holding.
  • Private Wealth Management Group first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Private Wealth Management Group's Elevance Health position peaked at $50.9K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.